Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates
Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients
New Clinical Trials for Cervical Cancer Now Available at Roswell Park
Roswell Park Provides Support, Clinical Trials for Young Adult Sarcoma Patients
Meet the Team: Rohit Gosain, MD
Utilizing Sacral Nerve Stimulation as a Treatment for Fecal Incontinence
Low-Dose Radiation Therapy for Arthritis
Exercise is Medicine in Oncology: The Moving Through Cancer Program
Myeloma vs. MUGA: Interpreting the Abnormal SPEP
Cardio-Oncology: Screening & Surveillance
Living-Donor Liver Transplant for Advanced Cancers
Modern Management of Borderline Resectable Pancreatic Cancer
Patients With a History of Breast Cancer who Desire Pregnancy
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
Sacituzumab Govitecan for Metastatic, HR-Positive, HER2-Negative Breast Cancer
Elacestrant for Advanced Estrogen Receptor-Positive Breast Cancer
Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients
Pediatric Precision Cancer Medicine Program
Innovative Endometrial Cancer Research Offers Fresh Promise for Patients
Rapid Blood Cancer Diagnostic Could Speed Decisions and Save Lives
Study Finds Unexpected Role for Odd-Man-Out Member of CDK Protein Family
Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row
Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy Cancer
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
